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Lavendamycin analogs have demonstrated potential as cancer-fighting agents but 
because of their high degree of toxicity and low solubility in pharmacological solvents, new 
analogs are required which will exhibit selective toxicity for tumor cells and also be soluble 
in solvents for administration as cancer-fighting drugs. The goal of this research is to 
produce an analog of Lavendamycin (1) with a high selective toxicity for ~K oncogene 
transformed cells and low toxicity for normal healthy cells. This can be accomplished 
through structure-activity relationship studies on a series of lavendamycins. To provide the 
series of analogs to be used in the studies, means by which various analogs may be 
produced must be devised. 
The goal of this project is to synthesize the AB-ring portion of a 7-N-
butyryllavendamycin via a Diels-Alder condensation. The synthesis of7-butyramido-2-
methyl-quinoline-5,8-dione (12) from the precursors 2-butyramido-6-bromobenzoquinone 
(6) and N-(O-t-butyldimethylsiloxy)-I-aza-2-methyl-l,3-butadiene (5) is the goal of this 
project. The Diels-Alder condensation is a general method for the production of a variety 
of quinolines and will lead to quinolines which are substituted at the C-7 as well as the C-6 
positions. The latter compounds are unavailable through our other synthetic schemes . 
--
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I, Historical Overview 
A, Background of Lavendanucin 
Lavendamycin (l) was first isolated from the fermentation broth of Strmtomyces 
lavendulae strain cc22030 in 1981 by Doyle, Nettleton, Balitz, and Grulich, researchers at 
Bristol Laboratories. 1 This compound was shown to exhibit antitumor activity but because 
of its extreme toxicity, lavendamycin cannot be used clinically as an antitumor agent. 2,3 
Lavendamycin is a dark red, crystalline solid with a melting point above 300°C and is 
insoluble in most organic solvents1 and is structurally very similar to another potent 
cytotoxic compound, streptonigrin (2). 
Mechanisms have been proposed by several groups to explain the cytotoxicity of 
streptonigrin and other quinones.4- 1o These mechanisms fall within two distinct classes of 
effects including those which interfere with the respiratory mechanism, and those which 
o 
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-affect the replication mechanisms of the cells.1 The mechanisms which interfere with 
cellular respiration affect the electron transport system in the inner mitochondrial 
membrane.4-6,9 Quinones have been shown to damage exposed DNA by cleaving the 
double helix at various places within the base sequence.1,3,lO At this time no single 
mechanism seems to explain fully the cytotoxicity of these compounds. 
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The primary goal of this research is the development of an analog of lavendamycin 
which possesses a high selective toxicity for tumor cells and which will not injure normal, 
healthy cells. To accomplish this goal, a series of structure-activity relationship (SAR) 
studies are in progress to determine the affects of alterations in the lavendamycin parent 
structure on its cytotoxic and antitumor activities. Streptonigrin has proven to exhibit 
strong antibiotic as well as antitumor activity. Lavendamycin, although less effective as an 
antibiotic, has demonstrated promising antitumor capabilities against rasK oncogenic 
tumors. 11 
8 
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B. Synthesis of Lavendamvcin and Analo,s 
Lavendamycin methyl ester (3) has been prepared by three groups. The compound 
was first prepared in 1984 by Kende and Ebetino, researchers at the University of 
Rochester, using tl-methyltryptophan as a precursor.12 In 1985, Boger and associates 
reported another method for the preparation of lavendamycin methyl ester (3).13 These two 
synthetic methods involved nine and twenty steps respectively and resulted in an overall 
yield of less than 2 %. For the last several years, Mohammad Behforouz of Ball State 
University has been working to find a more concise synthesis of lavendamycin methyl ester 
and several analogs using the Pictet-Spengler condensation. In 1993, a group of 
researchers at Ball State University led by Behforouz reported a very efficient synthesis of 
lavendamycin methyl ester (3).14 The method outlined by Behforouz et aL provides a 
practical method for the synthesis of lavendamycin methyl ester and various analogs 
(Scheme 1). This new method provided short and efficient syntheses for a variety of 
lavendamycin analogs and enabled researchers at Ball State University in collaboration with 
investigators at Eli Lilly to perform SAR studies of several N-acyl analogs. I I 
Scheme 1 
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II. Synthesis of the AB-rinr SYstem of 
Various Lavendamycin Analols 
Via Diels-Alder Condensations 
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The overall goal of this research is to synthesize derivatives of lavendamycin (1) 
that are soluble in pharmacological solvents and that exhibit high selective toxicity for 
tumor cells as compared to normal parent cells. The goal of this project is to synthesize 7-
butyramido-2-methylquinolin~5.8-dione via a Diels-AIde!" condensation of 2-butyramido-
6-bromobenzoquinone (6) with N-(O-t-butyldimethylsiloxy )-1-aza-2-methyl-1 ,3-butadiene 
(5). The 7-butyramido-2-methylquinoline-5,8-dione can then be oxidized to the aldehyde 
using selenium oxide in dioxane, and a Pictet-Spengler condensation with a tryptophan will 
provide the 7-N-butyryllavendamycin analog. 7-N-butyryllavendamycin analogs have 
previously been prepared, though starting with a 8-hydroxy-5,7-dinitro-2-
methylquinoline.15 The method involving the Diels-AIder condensation is superior in that 
analogs substituted at the 6 position of the quinoline ring system can also be prepared. 
Compounds prepared by this method will be included in SAR studies to determine the 
importance of groups at this position in the activity of lavendamycin analogs. 
--
111. Results and Discussion 
SYnthesis of 7-Butyramido-
2-Methylguinoline-5.8-Dione (12)17 
The preparation of 7-butyramido-2-methylquinoline-5,8-dione was accomplished 
by the procedure outlined in scheme n. 
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2-butyramido-6-bromobenzoquinone (6) was dissolved in chlorobenzene which had been 
stored over 4 Angstrom molecular sieves. N-(O-t-butyldimethylsiloxy)-I-aza-2-methyl-
1 ,3-butadiene was dissolved in dry chlorobenzene and the two solutions were mixed. The 
exclusion of water from the reaction mixture is very important, so molecular sieves were 
CH3 
added to the reaction mixture. The flask was immersed in an oil bath at 143°C. The 
product was obtained via the intermediate shown (15). The reaction mixture was poured 
directly onto the top of a flash silica gel column and the product isolated. The yield was 
30%. The reactants were prepared as reported below. 
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Synthesis of 2.4-Dibromo-6-Nitrophenol (8)16,17 
2,4-Dibromo-6-nitrophenol was prepared by the nitration of 2,4-dibromophenol by 
nitric acid in glacial acetic acid (scheme ill). 
Scheme III 
OH OH 
Br Br N02 HN03 
.. 
HOAc 
(7) (8) 
Br Br 
Glacial acetic acid was heated slightly to facilitate the dissolution of the 2,4-dibromophenol 
on a stirrerlhotplate. The reaction was highly exothermic and proceeded very rapidly. The 
concentrated nitric acid was added very slowly while the solution was rapidly stirred. If 
the reaction is allowed to proceed for longer than five minutes, a red oily substance 
becomes a contaminant and darkens the product. The reaction mixture was poured slowly 
into 250 ml of water and bright yellow crystals resulted. The solid was filtered out of the 
suspension to give 95 % of the pure product. 
--
Br 
(8) 
Preoaration of 2-Amino-4.6-Dibromophenol (9)17.18 
2-Amin0-4,6-dibromopheno1 (9) was prepared as shown in scheme IV. 
Scheme IV 
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Previous attempts to do this reaction indicated that the quality of the iron powder was of 
paramount importance in the rate of this reaction. The iron was therefore washed with 3 M 
HO, then rinsed with water (3x) and then with acetone (3x) and dried in an oven before 
addition to the reaction flask. This alteration of the published procedure resulted in a much 
more rapid reaction. Since the reaction is highly exothermic and is performed near the 
boiling point of the solvent system, care must be taken when adding iron powder. Several 
times in previous experiments, some of the reaction mixture was lost when it boiled over. 
When decanting the reaction mixture from the flask, using a large magnetic stirbar to keep 
the iron filings in the bottom of the flask helped immensely in preventing contamination of 
the product. The reaction mixture was poured into water and extracted with ethyl acetate. 
The extraction is very time consuming because of the formation of an emulsion at the 
interface between the two phases. The organic extracts were rotoevaporated and when a 
few milliliters of liquid remained, the residue was triturated with a small amount of water. 
The result is a very dark solid which must be pressed dry and dried under vacuum to 
remove water and acetic acid. The yield of this reaction was 88% of the expected yield. 
--
Pregaration of 2-Butvramido-4,6-DibromoJlhenvl 
Butyrate (10)17 
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The preparation of 2-butyramido-4,6-dibromophenyl butyrate was accomplished by 
the reaction of 9 with butyric anhydride according to scheme V. 
Scheme V 0 
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2-Propanol was the solvent of choice because of its ability to dissolve both 9 and butyric 
anhydride. The very foul smelling butyric anhydride must be handled carefully; because of 
its stench it can make one a social outcast if mishandled. The reaction proceeded for fifty 
minutes and the solvent was removed by rotoevaporation. The product was washed with 
petroleum ether. A small amount of 11 was in the product and a small amount of butyric 
anhydride remained in the product and defied attempts to remove it. The yield was 67%. 
The small amount of the product (10) was purified by flash column chromatography for 
analysis, but the mixture can easily be used in the next step, the hydrolysis to phenol 11. 
~-
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Attemoted Synthesis of 2-Butyramido-6-Bromobenzoguinone (6) 
Several attempts were made for the oxidation of the phenyl butyrate lOin the 
presence of eeric ammonium nitrate. The ester at the C-l position prevented the formation 
of the benzoquinone 6 in each of these cases. Other attempts were made involving 
potassium dichromate as the oxidizing agent, but these, too, were unsuccessful. 
Hydrolysis of the ester to the phenol II became an obvious necessity before the oxidation 
could be performed. 
Preparation of 2-Butyramido-4.6-Dibromophenol (11)17.18 
The hydrolysis of the ester at the C-l position of the ring was accomplished in the 
presence of sodium bicarbonate in methanol (scheme VI). 
Scheme VI 
OH 
Br 
Br 
2. He} (11) 
Br 
Br 
The addition of saturated sodium bicarbonate to a solution of 10 and 11 in methanol 
resulted in the precipitation of the basic salt. The removal of the excess sodium bicarbonate 
prior to the acidification of the reaction mixture is a vast improvement on the earlier 
method. The addition of a layer of petroleum ether on the top of the mixture before 
acidification allows the butyric acid formed to be removed from the product. The product 
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forms as a precipitate at tbe interface between the two layers. The yield of this reaction was 
77% and the structure of the product was confIrmed by NMR and mass spectroscopy. 
Preparation of 2-Butyramido-6-Bromobenzoguinone (6)18 
Scheme vn shows the process by which the preparation of 6 was accomplished. 
Scheme VII 
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Phenol 11 was dissolved in glacial acetic acid at low temperature, near the freezing point of 
the solvent. A solution of eeric ammonium nitrate was added dropwise and slowly. The 
reaction mixture changed from a light brown color to orange as the oxidizing agent was 
added. The reaction mixture was poured into ice water and extracted with ethyl acetate. 
The product was a mixture of the benzoquinone 6 and some other, less soluble product. 
The less soluble contaminant can be removed by fIltering the reaction mixture after adding it 
to the cold water. The resulting fIltrate can then be extracted to remove the product. The 
yield was low, primarily because the product is unstable and subject to nucleophilic 
substitution of the bromine by nucleophiles. The yield was 56% of the dark orange 
crystalline solid. 
Pre.garatioo of N-(Q-t-Butyldimethvlsiloxv)-
l-Aza-2-Methyl-l, 3-Butadie oe (5)19 
The butadiene required for the Diels-Alder condensation (5) was prepared by the 
reaction of methyl vinyl ketone (13) with O-t-butyl-dimethylsilyl hydroxylamine (14) 
(scheme YIn). 
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Scheme VIII 
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Methyl vinyl ketone (13) was stirred for 72 hours with a solution of O-t-butyldimethylsilyl 
hydroxyamine in dry dichloromethane. After 72 hours, the product was isolated by flash 
column chromatography and was found to consist of a mixture of E and Z. 
Interconversion between the two enantiomers is rapid at the high temperatures found in the 
reaction fonning (12), so the mixture was used as though it were only the Z isomer. The 
yield of the reaction was 61 %. 
--
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Summary of Synthetic Process 
Scheme IX is a summary of the synthetic method used to produce 7-butyramido-2-
methylquinoline-5,8-dione (12) from commercially available compounds (7), (13), and 
(14). The overall yield of the procedure was nearly 11 %. 
Scheme IX 
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Scheme IX (continued) 
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The Diels-Alder condensation is the primary source of this low overall yield and should be 
the focus of attempts to improve the synthesis. The oxidation of phenol 11 to quinone 6 is 
another source of a low yield in the synthesis. A method of preventing the formation of 
decomposition products of quinone 6 will also be useful for the application of this 
procedure to a larger scale. 
--
IV. Experimental 
A. General Information 
Solvents: Glacial acetic acid, 2-propanol, dry dichloromethane (dried 
over 4 Angstrom molecular sieve), Absolute ethanol, dry chlorobenzene 
distilled over calcium hydride, 70% aqueous ethanol, ethyl acetate, 
petroleum ether. 
Melting Points: Melting points determinations were performed with a 
Thomas Hoover capillary melting point apparatus and are not corrected. 
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Thin Layer Chromatography: TLCs were performed on Kodak silica 
gel sheets containing a fluorescent indicator. 
Mass Spectroscopy: Mass spectra were obtained on an Extrel ELQ 400 
mass spectrometer . 
. Nuclear Magnetic Resonance Spectroscopy eH NMR): NMR 
spectra were collected on a Varian Gemini 200 in deuterated chloroform 
with TMS as the internal reference. 
--, 
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B. Procedures 
Pre.garation of 2.4-Dibromo-6-NitroJ!henol (8)16,17 
Using a mortar and pestle, 25.03 g (99.5 mmol) of 2,4-dibromophenol (7) was 
crushed to a fine powder, and added to 50 ml of glacial acetic acid in a 250 ml beaker. The 
solvent was stirred over a stirrerlhot plate at room temperature until a clear solution was 
formed. When the 2,4-dibromophenol had completely dissolved, II ml of concentrated 
nitric acid were added. The re2ction mixture was stirred at 20°C for five minutes and then 
poured into 250 ml of distilled water in a 500 ml beaker. The yellow crystalline precipitate 
was collected by vacuum filtration and dried under vacuum to yield 28.1 g of 2,4-dibromo-
6-nitrophenol (94.5 mmol, 95% yield). The structure of the compound was verified by 
NMR spectroscopy. IH NMR data (COO}) b 11.08 (s, I, -OH); b 8.27 (d, 1,1=2.3 Hz, 
C-3 H); b 8.01 (d, 1,1=2.3 Hz, C-5 H) 
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Pre.Raration of 2-Amino-4.6-DibromQllhenol (9)17,18 
To a 500 ml three necked flask equipped with a mechanical stirrer, reflux condenser 
and thermometer, 200 ml of a 1: 1 80% ethanoVacetic acid were added. 2,4-dibrom0-6-
nitrophenol (8) (10.0 g, 33.7 mmol) was added and the mixture was stirred with gentle 
heating (60 °C) until a yellow solution was formed. Iron powder19 (15.4 g, 0.276 mol) 
was added to the reaction vessel portionwise over about 5 minutes (1 g each 20 sec) while 
vigorously stirring with the mechanical stirrer. The reaction mixture was heated to reflux 
for 15 minutes, at which time 0.2 ml of 12 N HCI were added. After an additional 15 
minutes, the reaction mixture was decanted into 500 ml of distilled water. The aqueous 
mixture was extracted with ethyl acetate (3x 250 ml). The organic extracts were then 
washed three times with 250 ml of distilled water. The organic layer was then 
rotoevaporated in a 45°C water bath until 10 ml of liquid remained. The remaining liquid 
was poured into 100 ml of distilled water. The precipitate was filtered and pressed. The 
filtrate was then extracted with 50 ml of ethyl acetate and the organic layer was 
rotoevaporated until 3-5 ml of liquid remained. The residue was then poured into 40 ml of 
distilled water and the precipitate was fIltered and pressed dry. The combined product was 
then dried under vacuum to yield 7.92 grams (88% yield) of2-amino-4,6-dibromophenol 
(9). 
The structure of the 2-amino-4,6-dibromophenol (9) was confirmed by NMR 
spectroscopy. lH NMR data (CnD]) b 6.98 (d, 1,1=2.1 Hz, C-5 H); b 6.79 (d, 1, 
1=2.0 Hz, C-3 H); b 5.38 (s, 1, -OB); b 3.94 (s, 2, -NHz) 
--
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Pregaration of 2-Butvramitlo-4.6-Dibromwhenvl Buarate (10) 
2-amin0-4,6-dibromophenol (9) (4.0 g, 15 mmol) was dissolved in 30 m1 of 2-
propanol in a 100 ml round-bottomed flask equipped with a reflux condenser. Butyric 
anhydride (5.0 ml, ) was added to the flask. The reaction mixture was stirred by magnetic 
stirrer while heating (reflux) for 50 minutes. The reaction mixture was rotoevaporated to 
remove the solvent (60 °C water bath) until 3-4 ml of liquid remained. The residue was 
then transferred to a 10 ml beaker and cooled in an ice bath. Light colored crystals formed 
and were removed from the liquid by vacuum filtration and washed with petroleum ether. 
The filtrate was then rotoevaporated (60 °C water bath) to condense it further and when 2-3 
m1 of liquid remained, the residue was again transferred to a 10 ml beaker and cooled in an 
ice bath. The resulting crystals were ftltered and washed with petroleum ether. The 
washed crystals were then dried under vacuum to give 4.1 g of2-butyramido-4,6-
dibromophenyl butyrate containing a small amount of 2-butyramido-4,6-dibromophenol 
contaminant. A small amount of 10 was purified by flash column chromatography (8 cm x 
1 cm) eluted with 5:1 pet. ether/ethyl acetate. 
The structure of 2-butyramido-4,6-dibromophenyl butyrate (10) was confrrmed by 
NMR and mass spectroscopic data. lH NMR data (CDCI3) b 8.47 (s, 1, NH); b 7.50 (d, 
1,1=2.1 Hz, C-5 H); b 7.16 (d, 1,1=2.1 Hz, C-3 H); b 2.68 (t, 2,1=7.3 Hz, -OCOCH2 -
); b 2.33 (t, 2, 1=7.3 HZ,-NHCOCH2-); b 1.88 (m, 2, 1=7.3, -OCOCH2CH2-); b 1.72 (m, 
2, 1=7.3 Hz, -NHCOCH2CH2-); b 1.10 (t, 3, J=7.4, ester-CH); b 1.04 (t, 3, 1=7.3, 
amido-CH). ElMS data, mle (relative intensity), 405 (46), 406 (61), 407 (70), 408 
(100), 409 (73), 410 (78). 
--
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AUefllllted SYnthesis of 2-Butvramido-6-BromobenzoQuinone 
Oxidation of the phenyl butyrate (10) was attempted prior to hydrolysis of the ester 
at the C-l position. 2-Butyramid0-4,6-dibromophenyl butyrate (10) (100 mg, .246 mmol) 
was dissolved in 5 ml of glacial acetic acid in a 10 ml two-necked, roundbottom flask with 
argon balloon and rubber membrane attached. A solution of cerium ammonium nitrate 
(.746 g, 1 mmol) in 1,0 ml of distilled water was added dropwise over a period of two 
minutes. The solution was stirred at 20°C for five minutes. One drop of concentrated HO 
was added to the reaction mixture, and the solution was stirred for an additional ten 
minutes. The reaction mixture was then poured into 50 ml of distilled water, filtered to 
remove a particulate solid and extracted with ethyl acetate (100 mI, 50 ml). The organic 
extracts were washed with water and dried over sodium sulfate. The solvent was then 
removed by rotoevaporation. The product was not obtained. 
Preparation of 2-Butvramido-4.6-Dibromophenol (11i7•18 
The 2-hutyramido-4,6-dibromophenyl butyrate (10) prepared in the last step was 
hydrolyzed to 2-butyramido-4,6-dibromophenol (11) in the presence of sodium 
bicarbonate. To a 150 ml beaker equipped with a magnetic stirrer, 1.75 g (4.3 mmol) of 2-
butyramido-4,6-dibromophenyl butyrate and 40 ml of methanol were added and stirred 
until a clear solution formed. Saturated sodium bicarbonate solution (15 ml) was added in 
2 ml portions over a period of 5 minutes with vigorous stirring. The resulting, slightly 
basic (pH 8.5) suspension was stirred for 30 minutes at room temperature. The 
suspension was then heated to boiling for 15 minutes. The mixture was allowed to cool to 
room temperature and the solid was then removed from the suspension by vacuum filtration 
and discarded (this solid material is excess sodium bicarbonate). The filtrate was 
transferred to a 150 ml beaker and 15 ml of petroleum ether were added to create a two 
phase system. Water (50 ml) was then added and the resulting system was allowed to sit 
for fifteen minutes. The two phase system was then acidified using 3 M HO to pH 4. A 
26 
precipitate formed at the interface between the two phases. The two phase system was 
stirred for five minutes and then allowed to sit for an additional five minutes. The solid 
material was then collected by vacuum filtration and washed with petroleum ether to give 
0.97 g of the phenol. The filtrate was then transferred to a 500 ml separatory funnel and 
the aqueous layer was drained into a 150 ml beaker. The aqueous layer was then cooled in 
an ice bath and white crystals formed which were filtered out by vacuum fIltration. The 
remaining filtrate was then transferred to a separatory funnel and extracted with ethyl 
acetate (2x 100 mI). The organic extracts were dried over sodium sulfate and the solvent 
removed by rotoevaporation. The combined mass of the three samples was 1.12 g (77 % 
yield) of pure 2-butyramido-4,6-dibromophenol (11). IH NMR data (CDCI3) b 7.97 (d, 1, 
J=1.8 Hz, C-5 H); b 7.77 (s, 1, -NH-); b 7.42 (d, 1, J=2.0 Hz, C-3 H); b 2.43 (t, 2, 
J=7.4 Hz, -NHCOCHz-); b 1.78 (m, 2, J=7.3 Hz, -NHCOCH2CHz-); b 1.03 (t, 3, 1=7.4 
Hz, amido-CH:3). ElMS data, mle (relative intensity), 335 (47), 336 (12),337 (M+, 
100), 338 (11), 339 (46), 340 (12). 
Preparation of 2-Butvramido-6-Bromobenzoguinone (6) 17,18 
Ceric ammonium nitrate (3.3 g, 6 mmol) was dissolved in 6 ml of distilled water 
and cooled in an ice bath. 2-butyramido-4,6-dibromophenol (11) (1.02 g, 3 mmol) was 
dissolved in 15 ml of acetic acid in a 50 mI three-necked, round-bottomed flask. Argon 
was streamed through the flask and out through a reflux condenser at the middle neck. The 
flask was cooled in an ice bath to 18°C and 7.5 mI of the eeric ammonium nitrate solution 
was added dropwise over a period of two minutes with vigorous stirring. The one phase 
solution was stirred while cooling in an ice bath to 10 °C for five minutes after the addition 
of the first half of the (NH4)2Ce(N03)6 solution. The second half of the eeric ammonium 
nitrate solution was then added dropwise over a period of two additional minutes and the 
mixture was then stirred for 10 minutes at 10°C. The reaction mixture was then poured 
---
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into 60 ml of ice water and extracted with ethyl acetate (2x 120 ml). After the organic layer 
had been washed with cooled, saturated NaCl solution (2x 100 ml) and dried over ~S04 
for thirty minutes, the mixture was concentrated by rotoevaporation until 5-6 ml remained. 
The residue was then cooled to 5 °C and the yellow crystals which formed were separated 
by vacuum filtration. The filtrate was further concentrated by rotoevaporation and cooled 
to give even more of the yellow-orange crystalline solid. The crystals were washed with 5 
ml of a 1:2 mixture of ethyl acetate and petroleum ethers and dried under vacuum at room 
temperature. 
The product was confIrmed by NMR spectroscopy. The yield was 430 mg (56%). 
IH NMR data (COCI3) b 8.09 (s, 1, -NH-); b 7.65 (d, 1, J=2.3 Hz, C-5 H); b 7.23 (d, 1, 
1=2.3 Hz, C-3 H); b 2.91 (t, 2, 1=7.3 Hz, -NHCOCHz-); b 1.73 (m, 2,1=7.3 Hz, 
-NHCOCH2CHz-); b 0.98 (t, 3, J=7.3 Hz, amido-CH3). ElMS data mJe (relative 
intensity) 270 (75),271 (88),272 (75),273 (100). 
-Pre.Raration of N -(Q-t-Bu(Jldime.thylsiloxy )-
l-Aza-2-Methyl-l.3-Butadiene (5)20 
28 
Freshly distilled methyl vinyl ketone (0.525 g, 7.5 mmol) was added to 5 ml of dry 
dichloromethane in a 20 ml two-necked round-bottom flask. Molecular sieve (4 Angstrom, 
2.65 g) was dried at 130 °C for three days, cooled under vacuum and added to the flask. A 
solution of O-t-butyldimethylsilyl) hydroxyamine (1.38 g, 9.4 mmol) in 5 ml of dry 
dichloromethane was added to the flask and the mixture was stirred at room temperature for 
72 hours. The reaction mixture was filtered and the filtrate was distilled under decreased 
pressure (20 mmHg, aspirator) from a 40 °C oil bath. Dichloromethane was collected at 
28°C. The residue was then purified by flash silica gel column chromatography (12 g silica 
gel, 1.5 cm x 16 cm column), using 350 ml of hexane as the eluent. Fractions containing 
either or both of the enantiomers were combined and the hexane was removed by 
rotoevaporation to yield 0.91 g (61 %) of a mixture of the E and Z isomers of the product 
as confrrmed by NMR spectroscopic data (see appendix). 
PreJlaration of 7-Butyramido-
2-M ethvl-Quinoline-5,8-Dione (12 )17 
2-butyramido-6-bromobenzoquinone (6) (70 mg, 0.26 mmol) was dissolved in 5 
ml of dry chlorobenzene. A sample (102 mg, 0.52 mmol) of N-(O-t-butyldimethylsiloxy)-
l-aza-2-methyl-l,3-butadiene (5) was dissolved in 1.0 ml of dry chlorobenzene. A 10 ml 
two-necked, round-bottom flask with magnetic stirbar, reflux condenser and all of the glass 
syringes, glassware and spatulas required for this synthesis were dried in an oven (l30°C 
for 2 days) and cooled in a desiccator. Rubber membranes were installed in one of the two 
necks of the flask and in the top of the reflux condenser. The apparatus was assembled and 
flushed with dried argon for two hours prior to the reaction. The solution of 2-butyramido-
6-bromobenzoquinone was injected into the flask by argon filled syringe. The solution of 
-29 
N-(O-t-butyldimethylsiloxy)-I-aza-2-methyl-I,3-butadiene was then added. The flask was 
covered with aluminum foil to exclude light from the apparatus and lowered into a 143°C 
oil bath and stirred for 20 hours. The reaction mixture was then poured onto the top of a 
flash silica gel column (I em x 8 cm) and eluted with 1:1 ethyl acetate and petroleum ether. 
Fractions containing 7-butyramido-2-methylquinoline-5,8-dione (12) were combined and 
rotoevaporated to remove the solvent. The result was 20.2 mg of the pure product (30% 
yield). 
The structure of the product was conftrmed by 1 H NMR spectroscopy. 1 H NMR 
data (COCI3) b 8.38 (s, 1, -NH-); b 8.31 (d, 1,1=8.1 Hz, C-4 H); b 7.93 (s, 1, C-6 H); 0 
7.56 (d, 1,1=7.9 Hz, C-3 H); b 2.78 (s, 3, C-2 -CH3); b 2.50 (t, 2, 1=7.3 Hz, 
-NHCH2-); 0 1.78 (m, 2, 1=7.3 Hz, -NHCH2CH2 -); b 1.02 (t, 3,1=6.0, 
-NHCH2CH2CH3) 
.-
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